HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Michel C Nussenzweig Selected Research

Michel C Nussenzweig Research Topics

Disease

90Infections
04/2022 - 01/2002
30COVID-19
02/2022 - 01/2020
11Viremia
01/2021 - 10/2013
9Neoplasms (Cancer)
01/2017 - 01/2007
8Lymphoma (Lymphomas)
01/2017 - 01/2007
5Genetic Translocation (Chromosomal Translocation)
01/2017 - 10/2007
5Malaria
02/2016 - 12/2002
5Genomic Instability
06/2013 - 05/2002
5Ataxia Telangiectasia (Louis Bar Syndrome)
02/2013 - 11/2004
5B-Cell Lymphoma (Lymphoma, B Cell)
01/2013 - 09/2007
4Reinfection
01/2022 - 01/2020
3HIV Infections (HIV Infection)
04/2022 - 12/2020
3Vesicular Stomatitis
12/2021 - 01/2021
3Severe Acute Respiratory Syndrome
06/2021 - 12/2020
3Pneumonia (Pneumonitis)
01/2021 - 10/2020
3Autoimmune Diseases (Autoimmune Disease)
10/2020 - 01/2004
3Inflammation (Inflammations)
04/2016 - 01/2002
3Acquired Immunodeficiency Syndrome (AIDS)
04/2015 - 06/2013
3Plasmacytoma
07/2012 - 08/2004
3Systemic Lupus Erythematosus (Libman-Sacks Disease)
07/2008 - 03/2005
2Breakthrough Infections
07/2022 - 10/2021
2Burkitt Lymphoma (Burkitt's Lymphoma)
07/2012 - 08/2004
2Nijmegen Breakage Syndrome
01/2007 - 12/2001
1Convalescence
10/2021
1Interstitial Lung Diseases (Interstitial Lung Disease)
01/2021
1Omsk Hemorrhagic Fever (Fever, Omsk Hemorrhagic)
01/2021
1Kyasanur Forest Disease
01/2021
1Louping Ill
01/2021
1Asymptomatic Infections
01/2021
1Chronic Hepatitis B
12/2020
1Emerging Communicable Diseases (Emerging Infectious Diseases)
10/2020
1Zika Virus Infection
01/2020
1Microcephaly
10/2019
1Leukemia
01/2017
1Lentivirus Infections
01/2017
1Persistent Infection
01/2017
1Hepatitis A (Hepatitis, Infectious)
05/2016
1Experimental Melanoma
06/2014
1Diphtheria
02/2014

Drug/Important Bio-Agent (IBA)

59AntibodiesIBA
04/2022 - 01/2004
34Broadly Neutralizing AntibodiesIBA
04/2022 - 12/2012
23VaccinesIBA
07/2022 - 10/2010
22Neutralizing AntibodiesIBA
07/2022 - 09/2012
13Monoclonal AntibodiesIBA
04/2021 - 09/2014
13DNA (Deoxyribonucleic Acid)IBA
01/2017 - 12/2001
10AntigensIBA
10/2021 - 01/2003
9EpitopesIBA
01/2022 - 04/2009
9Cytidine DeaminaseIBA
12/2014 - 11/2009
8Immunoglobulins (Immunoglobulin)IBA
01/2020 - 08/2004
6Proteins (Proteins, Gene)FDA Link
01/2020 - 12/2001
5mRNA VaccinesIBA
02/2022 - 06/2021
5AutoantibodiesIBA
01/2022 - 03/2005
5Antiviral Agents (Antivirals)IBA
04/2021 - 06/2020
5Glycoproteins (Glycoprotein)IBA
06/2016 - 06/2004
5Histones (Histone)IBA
11/2008 - 12/2001
4Messenger RNA (mRNA)IBA
07/2022 - 01/2021
4chenodeoxycholate sulfate conjugate (CDCS)IBA
04/2016 - 06/2012
3Immunoglobulin G (IgG)IBA
01/2021 - 07/2008
3Antigen Receptors (Antigen Receptor)IBA
10/2007 - 01/2007
2BNT162 VaccineIBA
12/2021 - 10/2021
2remdesivirIBA
04/2021 - 01/2021
2Single-Domain AntibodiesIBA
03/2021 - 01/2021
2CytokinesIBA
01/2021 - 05/2007
2Explosive Agents (Explosives)IBA
11/2020 - 06/2020
2InterferonsIBA
10/2020 - 05/2007
2Polysaccharides (Glycans)IBA
01/2019 - 02/2017
2Pharmaceutical PreparationsIBA
11/2018 - 04/2015
2AutoantigensIBA
09/2010 - 01/2002
21,2- di- (4- sulfamidophenyl)- 4- butylpyrazolidine- 3,5- dione (DSB)IBA
11/2009 - 12/2001
2Phosphotransferases (Kinase)IBA
11/2008 - 11/2004
2Mannose ReceptorIBA
11/2003 - 01/2003
12019-nCoV Vaccine mRNA-1273IBA
10/2021
1Immunoglobulin M (IgM)IBA
01/2021
1ogalvibartIBA
01/2021
1Immunoglobulin A (IgA)IBA
01/2021
1crexavibartIBA
01/2021
1Prednisolone (Predate)FDA LinkGeneric
01/2021
1Recombinant ProteinsIBA
10/2020
1Biomarkers (Surrogate Marker)IBA
10/2020
1ProteomeIBA
10/2020
1Antigen-Antibody Complex (Immune Complex)IBA
01/2019
1Anti-Retroviral Agents (Antiretroviral Agents)IBA
11/2018
1Bispecific AntibodiesIBA
01/2018
1HLA-B57 antigenIBA
01/2017
1Anti-Bacterial Agents (Antibiotics)IBA
04/2016
1Indicators and Reagents (Reagents)IBA
04/2015
1Poly I-CIBA
06/2014
1LigandsIBA
06/2014
1Heparin-binding EGF-like Growth Factor (HB-EGF)IBA
02/2014
1Interleukin-23 (Interleukin 23)IBA
09/2013
1Interleukin-22 (IL-22)IBA
09/2013
1Alanine (L-Alanine)FDA Link
06/2013
1Immunoglobulin IsotypesIBA
06/2013
1flt3 ligand protein (flt3 ligand)IBA
06/2013

Therapy/Procedure

12Therapeutics
04/2022 - 08/2009
7Immunotherapy
01/2022 - 10/2013
5Art Therapy
04/2022 - 10/2013
1Aftercare (After-Treatment)
01/2021
1Injections
01/2019
1Highly Active Antiretroviral Therapy (HAART)
11/2018